| 1 |
Thomas Chaigneau, Lina Aguilera Munoz, Caroline Oger, Clémence Gourdeau, Olivia Hentic, Lucie Laurent, Nelly Muller, Marco Dioguardi Burgio, Marie-Pauline Gagaille, Philippe Lévy, Vinciane Rebours, Pascal Hammel, Louis de Mestier. Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimens. Ther Adv Med Oncol 2023;15:17588359231163776. [ DOI: 10.1177/17588359231163776] [Reference Citation Analysis]
|
| 2 |
Bhattacharya S. An empirical review on the resistance mechanisms of epidermal growth factor receptor inhibitors and predictive molecular biomarkers in colorectal cancer. Crit Rev Oncol Hematol 2023;183:103916. [PMID: 36717006 DOI: 10.1016/j.critrevonc.2023.103916] [Reference Citation Analysis]
|
| 3 |
Ben Mahmoud IT, Ben Said A, Berguiga S, Houij R, Cherif I, Hamdi A, Ben Ayed W, Limayem I. Incidence and risk factors associated with development of oxalipatin-induced acute peripheral neuropathy in colorectal cancer patients. J Oncol Pharm Pract 2023;29:311-8. [PMID: 34918549 DOI: 10.1177/10781552211068138] [Reference Citation Analysis]
|
| 4 |
Abd-Elmawla MA, Abdelalim E, Ahmed KA, Rizk SM. The neuroprotective effect of pterostilbene on oxaliplatin-induced peripheral neuropathy via its anti-inflammatory, anti-oxidative and anti-apoptotic effects: Comparative study with celecoxib. Life Sci 2023;315:121364. [PMID: 36610639 DOI: 10.1016/j.lfs.2022.121364] [Reference Citation Analysis]
|
| 5 |
Zhou L, Yang H, Wang J, Liu Y, Xu Y, Xu H, Feng Y, Ge W. The Therapeutic Potential of Antioxidants in Chemotherapy-Induced Peripheral Neuropathy: Evidence from Preclinical and Clinical Studies. Neurotherapeutics 2023. [PMID: 36735180 DOI: 10.1007/s13311-023-01346-8] [Reference Citation Analysis]
|
| 6 |
Luo ZD, Wang YF, Zhao YX, Yu LC, Li T, Fan YJ, Zeng SJ, Zhang YL, Zhang Y, Zhang X. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. World J Gastroenterol 2023; 29(1): 1-18 [PMID: 36683709 DOI: 10.3748/wjg.v29.i1.1] [Reference Citation Analysis]
|
| 7 |
Man S, Xie L, Liu X, Wang G, Liu C, Gao W. Diosgenin relieves oxaliplatin-induced pain by affecting TLR4/NF-κB inflammatory signaling and the gut microbiota. Food Funct 2023;14:516-24. [PMID: 36520071 DOI: 10.1039/d2fo02877h] [Reference Citation Analysis]
|
| 8 |
Yang HY, Wu J, Lu H, Cheng ML, Wang BH, Zhu HL, Liu L, Xie M. Emodin suppresses oxaliplatin-induced neuropathic pain by inhibiting COX2/NF-κB mediated spinal inflammation. J Biochem Mol Toxicol 2023;37:e23229. [PMID: 36184831 DOI: 10.1002/jbt.23229] [Reference Citation Analysis]
|
| 9 |
Liu M, Mai JW, Luo DX, Liu GX, Xu T, Xin WJ, Lin SY, Li ZY. NFATc2-dependent epigenetic downregulation of the TSC2/Beclin-1 pathway is involved in neuropathic pain induced by oxaliplatin. Mol Pain 2023;19:17448069231158289. [PMID: 36733258 DOI: 10.1177/17448069231158289] [Reference Citation Analysis]
|
| 10 |
Wang H, Quan J, Deng Y, Chen J, Zhang K, Qu Z. Utilizing network pharmacological analysis to investigate the key targets and mechanisms of kaempferol against oxaliplatin-induced neurotoxicity. Toxicol Mech Methods 2023;33:38-46. [PMID: 35574720 DOI: 10.1080/15376516.2022.2069531] [Reference Citation Analysis]
|
| 11 |
Wang C, Chen S, Jiang W. Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials. Front Pharmacol 2022;13:1080888. [PMID: 36618919 DOI: 10.3389/fphar.2022.1080888] [Reference Citation Analysis]
|
| 12 |
Liu X, Wang H, Wang X, Jiang X, Jin Y, Han Y, Zhang Z. Identification and verification of inflammatory biomarkers for primary sjögren’s syndrome.. [DOI: 10.21203/rs.3.rs-2360426/v1] [Reference Citation Analysis]
|
| 13 |
Lin T, Hu L, Hu F, Li K, Wang CY, Zong LJ, Zhao YQ, Zhang X, Li Y, Yang Y, Wang Y, Jiang CY, Wu X, Liu WT. NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy. Cancer Immunol Res 2022;10:1542-58. [PMID: 36255412 DOI: 10.1158/2326-6066.CIR-22-0197] [Reference Citation Analysis]
|
| 14 |
Li W, Xiao L, Yu ZQ, Li M, Wang XM, Liu D, Zhang CL. Attention and Intervention of Oncologists on Oxaliplatin-induced Adverse Reactions in Mainland China: A Cross-sectional Internet-based Survey. Curr Med Sci 2022;42:1319-24. [PMID: 36245029 DOI: 10.1007/s11596-022-2634-0] [Reference Citation Analysis]
|
| 15 |
Zhang N, Sundquist J, Sundquist K, Ji J. Use of Selective Serotonin Reuptake Inhibitors Is Associated with a Lower Risk of Colorectal Cancer among People with Family History. Cancers (Basel) 2022;14. [PMID: 36497383 DOI: 10.3390/cancers14235905] [Reference Citation Analysis]
|
| 16 |
Chan K, Lui L, Lam Y, Yu K, Lau K, Lai M, Lau W, Tai L, Mak C, Bian Z, Zhong LL. Efficacy and safety of electroacupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a single-blinded, randomized, sham-controlled trial. Acupunct Med 2022. [DOI: 10.1177/09645284221125421] [Reference Citation Analysis]
|
| 17 |
Kanbayashi Y, Ishikawa T, Kuriu Y, Otsuji E, Takayama K. Predictors for development of oxaliplatin-induced peripheral neuropathy in cancer patients as determined by ordered logistic regression analysis. PLoS ONE 2022;17:e0275481. [DOI: 10.1371/journal.pone.0275481] [Reference Citation Analysis]
|
| 18 |
Takaku S, Sango K. Pretreatment with Zonisamide Mitigates Oxaliplatin-Induced Toxicity in Rat DRG Neurons and DRG Neuron–Schwann Cell Co-Cultures. IJMS 2022;23:9983. [DOI: 10.3390/ijms23179983] [Reference Citation Analysis]
|
| 19 |
Mao Q, Tian L, Wei J, Zhou X, Cheng H, Zhu X, Li X, Gao Z, Zhang X, Liang L. Transcriptome analysis of microRNAs, circRNAs, and mRNAs in the dorsal root ganglia of paclitaxel-induced mice with neuropathic pain. Front Mol Neurosci 2022;15:990260. [DOI: 10.3389/fnmol.2022.990260] [Reference Citation Analysis]
|
| 20 |
Gao Q, Feng J, Liu W, Wen C, Wu Y, Liao Q, Zou L, Sui X, Xie T, Zhang J, Hu Y. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Adv Drug Deliv Rev 2022;188:114445. [PMID: 35820601 DOI: 10.1016/j.addr.2022.114445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Wang FJ, Shi S, Wang YQ, Wang K, Fan SD, Zhang YN, Feng CC, Ju ZY. Protective Mechanism of Electroacupuncture on Peripheral Neurotoxicity Induced by Oxaliplatin in Rats. Chin J Integr Med 2022. [PMID: 35799085 DOI: 10.1007/s11655-022-2896-1] [Reference Citation Analysis]
|
| 22 |
Chen X, Wang H, Zhang Z, Xu Y, An X, Ai X, Li L. Case Report: Oxaliplatin-Induced Third-Degree Atrioventricular Block: First Discovery of an Important Side-Effect. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.900406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Slagter AE, Caspers IA, van Grieken NCT, Walraven I, Lind P, Meershoek-Klein Kranenbarg E, Grootscholten C, Nordsmark M, van Sandick JW, Sikorska K, van de Velde CJH, Jansen EPM, Verheij M, van Laarhoven HWM, Cats A. Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer. Cancers (Basel) 2022;14:2963. [PMID: 35740628 DOI: 10.3390/cancers14122963] [Reference Citation Analysis]
|
| 24 |
Bekiari C, Tekos F, Skaperda Z, Argyropoulou A, Skaltsounis AL, Kouretas D, Tsingotjidou A. Antioxidant and Neuroprotective Effect of a Grape Pomace Extract on Oxaliplatin-Induced Peripheral Neuropathy in Rats: Biochemical, Behavioral and Histopathological Evaluation. Antioxidants (Basel) 2022;11:1062. [PMID: 35739960 DOI: 10.3390/antiox11061062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Li M, Yang N, Xu W. Synthesis of a new water-soluble hexacarboxylated tribenzotriquinacene derivative and its competitive host–guest interaction for drug delivery. Beilstein J Org Chem 2022;18:539-48. [DOI: 10.3762/bjoc.18.56] [Reference Citation Analysis]
|
| 26 |
Yi L, Li S, Hou A, Dai L. Preliminary study of astragaloside IV on oxaliplatin-induced peripheral neurotoxicity in rats. Eur J Inflamm 2022;20:1721727X2210941. [DOI: 10.1177/1721727x221094157] [Reference Citation Analysis]
|
| 27 |
Prutianu I, Alexa-Stratulat T, Cristea EO, Nicolau A, Moisuc DC, Covrig AA, Ivanov K, Croitoru AE, Miron MI, Dinu MI, Ivanov AV, Marinca MV, Radu I, Gafton B. Oxaliplatin-induced neuropathy and colo-rectal cancer patient’s quality of life: Practical lessons from a prospective cross-sectional, real-world study. World J Clin Cases 2022; 10(10): 3101-3112 [DOI: 10.12998/wjcc.v10.i10.3101] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Xu X, Jia L, Ma X, Li H, Sun C. Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity. Front Pharmacol 2021;12:792331. [PMID: 35095502 DOI: 10.3389/fphar.2021.792331] [Reference Citation Analysis]
|
| 29 |
Reis AS, Martins CC, da Motta KP, Paltian JJ, Costa GP, Alves D, Luchese C, Wilhelm EA. Interface of Aging and Acute Peripheral Neuropathy Induced by Oxaliplatin in Mice: Target-Directed Approaches for Na+, K+-ATPase, Oxidative Stress, and 7-Chloro-4-(phenylselanyl) quinoline Therapy. Mol Neurobiol 2022. [PMID: 35023057 DOI: 10.1007/s12035-021-02659-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Dyachenko IA, Palikova YA, Palikov VA, Korolkova YV, Kazakov VA, Egorova NS, Garifulina AI, Utkin YN, Tsetlin VI, Kryukova EV. α-Conotoxin RgIA and oligoarginine R8 in the mice model alleviate long-term oxaliplatin induced neuropathy. Biochimie 2021:S0300-9084(21)00301-1. [PMID: 34979156 DOI: 10.1016/j.biochi.2021.12.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 31 |
Lamoine S, Cumenal M, Barriere DA, Pereira V, Fereyrolles M, Prival L, Barbier J, Boudieu L, Brasset E, Bertin B, Renaud Y, Miot-Noirault E, Civiale MA, Balayssac D, Aissouni Y, Eschalier A, Busserolles J. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice. Int J Mol Sci 2021;23:98. [PMID: 35008525 DOI: 10.3390/ijms23010098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 32 |
Yu Z, Huang R, Zhao L, Wang X, Shangguan X, Li W, Li M, Yin X, Zhang C, Liu D. Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study. Front Oncol 2021;11:757196. [PMID: 34745993 DOI: 10.3389/fonc.2021.757196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A, Mak T, Marshall A, Frank B, Malik RA, Alam U. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncol Ther 2021;9:385-450. [PMID: 34655433 DOI: 10.1007/s40487-021-00168-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 34 |
Hou X, Zhang P, Du H, Chu W, Sun R, Qin S, Tian Y, Zhang Z, Xu F. Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer. Front Pharmacol 2021;12:725583. [PMID: 34603035 DOI: 10.3389/fphar.2021.725583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 35 |
Yang Y, Feng M, Bai L, Zhang M, Zhou K, Liao W, Lei W, Zhang N, Huang J, Li Q. The Effects of Autophagy-Related Genes and lncRNAs in Therapy and Prognosis of Colorectal Cancer. Front Oncol 2021;11:582040. [PMID: 33777735 DOI: 10.3389/fonc.2021.582040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 36 |
van Haren FGAM, Steegers MAH, Thijssen M, van der Wal SEI, Vissers KCP, Engels Y. Qualitative Evaluation of the Influence of Acute Oxaliplatin-Induced Peripheral Neuropathy on Quality of Life and Activities of Daily Life. Pain Pract 2021;21:513-22. [PMID: 33301649 DOI: 10.1111/papr.12981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
